|
|
|
Volumn 58, Issue 3, 2003, Pages 299-312
|
|
A History of Adverse Drug Experiences: Congress Had Ample Evidence to Support Restrictions on the Promotion of Prescription Drugs
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CARDIOVASCULAR AGENT;
CHLORAMPHENICOL;
CHLORPROMAZINE;
DEPROL;
DIETHYLSTILBESTROL;
DRUG;
GASTROINTESTINAL AGENT;
LITHIUM;
NEUROLEPTIC AGENT;
THIORIDAZINE;
TRANQUILIZER;
ADVERSE DRUG REACTION;
DRUG EFFICACY;
DRUG FATALITY;
DRUG INDICATION;
DRUG INDUSTRY;
DRUG LEGISLATION;
DRUG MANUFACTURE;
DRUG MARKETING;
DRUG SAFETY;
FOOD AND DRUG ADMINISTRATION;
GOVERNMENT;
GRANULOCYTOSIS;
HEALTH PROMOTION;
HISTORY OF MEDICINE;
HUMAN;
LAW;
MENTAL DISEASE;
MOTOR DYSFUNCTION;
PREMATURITY;
PRESCRIPTION;
REPRODUCTIVE TOXICITY;
REVIEW;
SIDE EFFECT;
SUDDEN DEATH;
TARDIVE DYSKINESIA;
ADVERSE DRUG REACTION REPORTING SYSTEMS;
ADVERTISING;
DRUG INDUSTRY;
HUMANS;
PATIENT PARTICIPATION;
PHARMACEUTICAL PREPARATIONS;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 0242330294
PISSN: 1064590X
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (12)
|
|
References (0)
|